Explorative Analysis of Treatment Outcomes of Levofloxacin- and Moxifloxacin-Based Regimens and Outcome Predictors in Ethiopian MDR-TB Patients: A Prospective Observational Cohort Study-Reference-Cited by-同舟云学术

Explorative Analysis of Treatment Outcomes of Levofloxacin- and Moxifloxacin-Based Regimens and Outcome Predictors in Ethiopian MDR-TB Patients: A Prospective Observational Cohort Study

Published:2021-12 Issue: Volume:Volume 14 Page:5473-5489
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Sidamo Temesgen^ORCID,Shibeshi Workineh,Yimer Getnet,Aklillu Eleni^ORCID,Engidawork Ephrem^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference79 articles.

1. World Health Organization. Global Tuberculosis Report. Geneva, Switzerland: World Health Organization; 2018.

2. World Health Organization. Global Tuberculosis Report. Geneva, Switzerland: World Health Organization; 2016.

3. World Health Organization. Global Tuberculosis Report. Geneva, Switzerland:: World Health Organization; 2019.

4. World Health Organization. Global tuberculosis report 2020, 2020: 1–232.

5. Cost of treatment for multidrug-resistant tuberculosis in South Korea

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary Analysis;Tropical Medicine and Infectious Disease;2024-09-11

2. Breaking barriers: The potential of nanosystems in antituberculosis therapy;Bioactive Materials;2024-09

3. Integrative analysis of multimodal patient data identifies personalized predictors of tuberculosis treatment prognosis;iScience;2024-02

4. Assessing Treatment Efficacy and Determinants of Outcome in Isoniazid Mono-resistant Tuberculosis Patients: A Prospective Observational Study in Gujarat;Acta Medica International;2024-01

5. Clinical efficacy of chemotherapy regimen combined with Levofloxacin in patients with Pulmonary Tuberculosis complicated with Type-2 Diabetes;Pakistan Journal of Medical Sciences;2023-01-26